## Abstract We previously reported that a combination of serum hepatocyte growth factor (HGF) and carcinoembryonic antigen (CEA) was useful for selecting early‐stage colorectal cancer patients with aggressive disease. The aim of the present study was to determine whether serum HGF could provide CEA
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
✍ Scribed by Wallin, U; Glimelius, B; Jirström, K; Darmanis, S; Nong, R Y; Pontén, F; Johansson, C; Påhlman, L; Birgisson, H
- Book ID
- 109838737
- Publisher
- Nature Publishing Group
- Year
- 2011
- Tongue
- English
- Weight
- 677 KB
- Volume
- 104
- Category
- Article
- ISSN
- 0007-0920
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This study examines anastomotic leaks as a potential influence on the long term outcome of patients with colorectal cancer. 167 patients were studied who had clinical and radiological assessment of anastomotic integrity in the post-operative period, following potentially curative resections for left
## Abstract Transforming growth factor β1 (TGF‐β1) is thought to be involved in cancer growth and progression. TGF‐β1 changes to its active form after being secreted in its latent form. Our aim was to clarify the significance of plasma concentrations of active and total TGF‐β1 of patients with colo